Anders Bjartell
61 – 70 of 372
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
- Contribution to journal › Article
-
Mark
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells
- Contribution to journal › Article
-
Mark
Lymph swelling after radical prostatectomy and pelvic lymph node dissection
- Contribution to journal › Article
-
Mark
Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer
- Contribution to journal › Article
-
Mark
Reply to Wei Zhang So, Ziting Wang, and Ho Yee Tiong's Letter to the Editor re : Anna Lantz, David Bock, Olof Akre, et al. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up. Eur Urol 2021;80:650–60
- Contribution to journal › Letter
-
Mark
Establishing metastatic prostate cancer quality indicators using a modified Delphi approach
- Contribution to journal › Article
-
Mark
Re : Performance of a Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography–derived Risk-stratification Tool for High-risk and Very High-risk Prostate Cancer
- Contribution to journal › Debate/Note/Editorial
-
Mark
Learning curve for robot-assisted laparoscopic radical prostatectomy in a large prospective multicentre study
- Contribution to journal › Article
-
Mark
Interval Changes in PSMA PET/CT During Radium-223 Therapy for Metastatic Bone Disease from Castration-Resistant Prostate Cancer
- Contribution to journal › Article
-
Mark
Designing and Implementing a Population-based Organised Prostate Cancer Testing Programme
- Contribution to journal › Article
